A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics-Reference-Cited by-同舟云学术

A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics

Published:2012-09 Issue:9 Volume:1 Page:2
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Quinney SK¹¹,Mohamed AN²,Hebert MF³⁴,Haas DM¹¹,Clark S⁵,Umans JG⁶⁷,Caritis SN⁸,Li L⁹,

Affiliation:

1. Department of Obstetrics and Gynecology and Department of Medicine Division of Clinical Pharmacology; Indiana University School of Medicine; Indianapolis Indiana USA

2. Department of Pharmaceutical Practice; Purdue University College of Pharmacy; Indianapolis Indiana USA

3. Department of Pharmacy; University of Washington, Seattle; Washington USA

4. Department of Obstetrics and Gynecology; University of Washington, Seattle; Washington USA

5. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology; University of Texas Medical Branch; Galveston Texas USA

6. Department of Medicine; Georgetown University, Washington; District of Columbia USA

7. Department of Biostatistics; Epidemiology, Outcomes, and Data Management, MedStar Research Institute; Hyattsville Maryland USA

8. Divisions of Reproductive Infectious Diseases and Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Women's Hospital; University of Pittsburgh Medical Center; Pittsburgh Pennsylvania USA

9. Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics; Indiana Institute of Personalized Medicine Indiana University School of Medicine; Indianapolis Indiana USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2012.5/fullpdf

Reference47 articles.

1. Prescription drug use during pregnancy in developed countries: a systematic review;Daw;Pharmacoepidemiol. Drug Saf.,2011

2. A comprehensive ethical framework for responsibly designing and conducting pharmacologic research that involves pregnant women;McCullough;Am. J. Obstet. Gynecol.,2005

3. The second wave: Toward responsible inclusion of pregnant women in research;Lyerly;Int. J. Fem. Approaches Bioeth.,2008

4. Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002);Rowland;AAPS PharmSci,2004

5. Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments;Corley;Crit. Rev. Toxicol.,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes;Drugs in R&D;2024-05-29

2. Mechanistic Framework to Predict Maternal‐Placental‐Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach;The Journal of Clinical Pharmacology;2024-02-02

3. Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model;British Journal of Clinical Pharmacology;2023-07-07

5. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review;European Journal of Clinical Pharmacology;2022-09-15